Ruxolitinib
Clinical safety rating: avoid
Contraindicated (not allowed)
Mechanism information is still being processed. Check the DailyMed link in the sidebar for the official prescribing information.
Tablet 5 mg - Oral
Clinical note
Strong CYP3A4 inhibitors may increase levels Can cause serious infections and myelosuppression.
Thrombocytopenia
Loading safety data…